Johnson & Johnson (NYSE: JNJ) is in the spotlight with CEO Joaquin Duato discussing game-changing cancer drugs and medical devices, including cardio products. Despite talc lawsuits, J&J is winning cases and plans to continue fighting. The company develops pharmaceuticals and medical technologies in various fields. AI stocks may offer better investment potential.

Read more at Yahoo Finance: Jim Cramer Believes Lawsuits Are No Longer a Major Threat to Johnson & Johnson